Role of the host microenvironment on the expression of VEGF-subtypes in squamous cell carcinoma

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1503-1506

  Brieger, Jürgen ^a   Vlachtsis, Konstantinos ^a   Gieringer, Rita ^a   Mann, Wolf ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Quantitative PCR analysis; SCC; Tumor progression; VEGF isoform; Xenotransplantation

Indexed keywords

ISOPROTEIN; MESSENGER RNA; VASCULOTROPIN A;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER TRANSPLANTATION; HEAD AND NECK TUMOR; HUMAN; LUNG TUMOR; METABOLISM; MICROCIRCULATION; MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ENDOTHELIUM, VASCULAR; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MICE; MICROCIRCULATION; NEOPLASM TRANSPLANTATION; PROTEIN ISOFORMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2142801118     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1503     Document Type: Article

References (25)

1. Houck KA, Ferrara N, Cachianes G, Li B and Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814, 1991.
2. Ferrara N, Houck KA, Jakeman LB, Winer J and Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47: 211-218, 1991.
3. Houck KA, Leung DW, Rowland AM, Winer J and Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037, 1992. (Pubitemid 23014012)
4. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E and Neufeld G: VEGF 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem 272: 7151-7158, 1997. (Pubitemid 27166421)
5. Park JE, Keller GA and Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the sub-epithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326, 1993. (Pubitemid 24045761)
6. Cohen T, Gitay Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ and Neufeld G: VEGF 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322-11326, 1995.
7. Wellmann S, Taube T, Paal K, v. Einsiedel HG, Geilen W, Seifert G, Eckert C, Henze G and Seeger K: Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology. Clin Chem 47: 654-660, 2001. (Pubitemid 32275807)
8. Burchardt T, Burchardt M, Chen MW, Buttyan R, De la Taille A and Shabsigh R: Expression of VEGF splice variants 144/145 and 205/206 in adult male tissues. IUBMB Life 48: 405-408, 1999.
9. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M: Vascular endothelial growth factor (VEGF) mRNA isoform expression patern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998-1002, 1998. (Pubitemid 28101792)
10. Oshika Y, Nakamura M, Tokunaga T, Ozeki Y, Fukushima Y, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Tamaoki N and Ueyama Y: Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 12: 541-544, 1998. (Pubitemid 28097280)
11. Ohta Y, Watanabe Y, Murakami S, Oda M, Hayashi Y, Nonomura A, Endo Y and Sasaki T: Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer 76: 1041-1045, 1997. (Pubitemid 27434661)
12. Scott PAE, Smith K, Poulsom R, De Benedetti A, Bichnell R and Harris AL: Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to e1F-4E. Br J Cancer 77: 2120-2128, 1998. (Pubitemid 28263931)
13. Tomisawa M, Tokunaga T, Oshika Y, Tsuchida T, Fukushima Y, Sato H, Kijima H, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M: Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularization in renal cell carcinoma. Eur J Cancer 35: 133-137, 1999. (Pubitemid 29079504)
14. Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, Fukuda H, Nakano H, Abe S, Tateishi A, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y and Nakamura M: Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35: 1089-1093, 1999. (Pubitemid 29339192)
15. Li N, Kanda K, Fukumori T, Inoue Y, Nishitani M, Kanayama H and Kagawa S: Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer. Urol Oncol 6: 10-15, 2000.
16. Oshika Y, Nakamura M, Tokunaga T, Ohnishi Y, Abe Y, Tsuchida T, Tomil Y, Kijima H, Yamazaki H, Ozeki Y, Tamaoki N and Ueyama Y: Ribozyme approach to down-regulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC). Eur J Cancer 36: 2390-2396, 2000.
17. Tokunaga T, Kijima H, Oshika Y, Fukushima Y, Abe Y, Ohnishi Y, Yamazaki H, Tsuchida T, Makuuchi H, Tamaoki N, Ueyama Y and Nakamura M: Aberrant isoform of vascular endothelial growth factor 189 is correlated with xeno-transplantability of human esophageal cancer. Oncol Rep 5: 1115-1118, 1998. (Pubitemid 28372571)
18. Okamoto K, Oshika Y, Fukushima Y, Ohnishi Y, Tokunaga T, Tomii Y, Kijima H, Yamazaki H, Neyama Y, Tamaoki N and Nakumura M: Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189. Oncol Rep 6: 1201-1204, 1999.
19. Vlachtsis K, Brieger J, Kim DW, Gieringer R, Hast J, Hengstler JG and Mann W: Quantitative analysis of VEGF-isoforms in head and neck squamous cell carcinoma cell lines: relation to xenotransplantability and tumour progression in mice. Oncol Rep 9: 1133-1138, 2002.
20. Monsky WL, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D and Jain RK: Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 8: 1008-1013, 2002. (Pubitemid 35177349)
21. Fukumura D, Yuan F, Monsky WL, Chen Y and Jain RK: Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151: 679-688 1997. (Pubitemid 27385599)
22. Gohongi T, Fukumura D, Boucher Y, Yun CO, Soff GA, Compton C, Todoroki T and Jain RK: Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor betal. Nat Med 5: 1203-1208, 1999. (Pubitemid 29474428)
23. Tsuzuki Y, Mouta Carreira C, Bockhorn M, Xu L, Jain RK and Fukumura D: Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 81: 1439-1451, 2001. (Pubitemid 32980166)
24. Roberts WG, Delaat J, Nagane M, Huang S, Cavenee WK and Palade GE: Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol 153: 1239-1248, 1998. (Pubitemid 28465847)
25. Yoshiji H, Harris SR and Thorgeirsson UP: Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res 57: 3924-3928, 1997. (Pubitemid 27427677)